Loading page...
Loading page...
This round is closed. The next round and similar open calls are listed below. Synced from the EU Funding & Tenders Portal on 9 November 2026.
This call is closed. These open or upcoming calls fund the closest work.
Based on projects the EU funded on the same subject in this programme.
MELCAYANovel health care strategies for melanoma in children, adolescents and young adults
HORIZON-MISS-2021-CANCER-02-03 · 2022 · Official record ↗
ONCODIRONCODIR – Evidence-based Participatory Decision Making for Cancer Prevention through implementation research
HORIZON-MISS-2022-CANCER-01-01 · 2023 · Official record ↗
CO-CAPTAINCANCER PREVENTION AMONG INDIVIDUALS WITH MENTAL ILL-HEALTH: CO-ADAPTING AND IMPLEMENTING PATIENT NAVIGATION FOR PRIMARY CANCER PREVENTION
HORIZON-MISS-2022-CANCER-01-01 · 2023 · Official record ↗
IMPACTIMproving the outcome of Peritoneal and Pleural metastases using Aerosolized ChemoTherapy
HORIZON-MISS-2025-02-CANCER-03 · 2026 · Official record ↗
ENDEAVOREndoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for detecting cost effective surveillance strategies and prediction of cancer recurrence
HORIZON-MISS-2023-CANCER-01-03 · 2024 · Official record ↗
InBestSoilMonetary valuation of soil ecosystem services and creation of initiatives to invest in soil health: setting a framework for the inclusion of soil health in business and in the policy making process
HORIZON-MISS-2021-SOIL-02-05 · 2023 · Official record ↗
healthRiskADAPTUser-driven Health risk Assessment Services and Innovative ADAPTation options against Threats from Heatwaves, Air Pollution, Wildfire Emission and Pollen
HORIZON-MISS-2023-CLIMA-01-03 · 2024 · Official record ↗
LOESSLiteracy boost through an Operational Educational Ecosystem of Societal actors on Soil health
HORIZON-MISS-2022-SOIL-01-07 · 2023 · Official record ↗
Each one links to its EU funding record and the partners it works with: a starting list for building a consortium.
This topic aims to develop a wide capacity building programme between EU Member States/Associated Countries and Ukrainian cancer centres, to support improvement or development of research & innovation-related capacities and integration with cancer care.
To this end, proposals should aim at delivering results that are directed and tailored towards and contribute to all of the following expected outcomes:
Ukraine has a very high cancer burden with more than 155,000 new diagnoses every year[1]. The country has also one of the highest childhood cancer mortality rates globally[2]. Disparities in access and quality of cancer care in Ukraine were high before Russia's unprovoked aggression and worsened because of the conflict, which has also led to increased cancer mortality and morbidity, due to discontinuation of treatments and shortage of medical supplies.
Proposals should address all of the following:
A research capacity-building programme should be set up between EU Member States/Associated Countries and Ukraine, in order to support Ukraine to develop or to further improve research & innovation-related capacities of future or existing Cancer Infrastructures.
The capacity building programme should include the following components:
The capacity building programme should cover at least the following areas;
Gender-related aspects, with respect to representation in research and career pathways and any other relevant aspects, should be duly taken into account.
The research capacity-building programme should be tailored to the needs of the participating entities. This concerns in particular the required participants / stakeholder groups, duly reflecting health and research system specificities. The training module shall consist of balanced theoretical and practical parts, including simulations, case studies, group exercises, mutual learning exercises and on-site visits (when possible) to gather practical experience. Safety of participating staff/researchers should be prioritised.
Advantage should be taken to the extent possible of experience gained under current and previous initiatives such as CCI4EU[5], Jane[6], Jane 2[7], Crane[8], CanSERV[9] and others. The relevant EU research infrastructures in the life science domain[10] and other EU initiatives should be exploited for available research services, as appropriate.
[1] 04-ukraine-fact-sheet.pdf
[2] 9789289057615-eng.pdf
[3] Topics to be covered include but are not limited to study design, process of trial approval, ethical aspects, recruitment, staffing and training requirements including digital skills, data management and data analysis, organisational aspects, regulatory requirements, clinical core facilities, patient participation and empowerment
[4] e.g. interoperability of standards, data protection related aspects and others as appropriate
[5] CCI4EU
[6] Shaping the EU Networksof Expertise on cancer!
[7] Home - Jane 2
[8] CraNE4Health European Network of Comprehensive Cancer Centres
[9] canSERV - Cutting Edge Cancer Research Services Across Europe
[10] Home | LifeScience
1. Admissibility Conditions: Proposal page limit and layout
described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
2. Eligible Countries
described in Annex B of the Work Programme General Annexes.
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
3. Other Eligible Conditions
Subject to restrictions for the protection of European communication networks.
described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion
described in Annex C of the Work Programme General Annexes.
5a. Evaluation and award: Award criteria, scoring and thresholds
are described in Annex D of the Work Programme General Annexes.
5b. Evaluation and award: Submission and evaluation processes
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12.
are described in Annex F of the Work Programme General Annexes and the Online Manual.
5c. Evaluation and award: Indicative timeline for evaluation and grant agreement
described in Annex F of the Work Programme General Annexes.
6. Legal and financial set-up of the grants
Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, under ‘Simplified costs decisions’ or through this link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ls-decision_he_en.pdf]].
The granting authority may, up to 4 years after the end of the action, object to a transfer of ownership or to the exclusive licensing of results, as set out in the specific provision of Annex 5.
described in Annex G of the Work Programme General Annexes.
described in the [specific topic of the Work Programme]
Application and evaluation forms and model grant agreement (MGA):
Application form templates — the application form specific to this call is available in the Submission System
Standard application form (HE CSA)
Evaluation form templates — will be used with the necessary adaptations 
Standard evaluation form (HE CSA) 
Guidance
HE Programme Guide 
Model Grant Agreements (MGA)
Lump Sum MGA 
Call-specific instructions 
Detailed budget table (HE LS) 
Guidance: "Lump sums - what do I need to know?"
Additional documents:
HE Main Work Programme 2026-2027 – 1. General Introduction
HE Main Work Programme 2026-2027 – 12. Missions
HE Main Work Programme 2026-2027 – 15. General Annexes
HE Programme Guide
HE Framework Programme 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation 2024/2509
Decision authorising the use of lump sum contributions under the Horizon Europe Programme
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual 
Funding & Tenders Portal Terms and Conditions 
Funding & Tenders Portal Privacy Statement
Confirm the current call documents and submission conditions with the funding authority.
View on EU portal ↗Source: EU Funding & Tenders Portal · synced 2026-11-09
A free account keeps your shortlist and sends deadline reminders. The EUACC connector brings this call, its FAQs, past winners and similar calls into Claude or ChatGPT, so you can check fit and draft with sources.